Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism DprE1 inhibitors(FAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC15H9ClN4O4S2 |
InChIKeyCKPNJBFBQZGYKK-UHFFFAOYSA-N |
CAS Registry1630090-61-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Mycobacterium Infections | Discovery | CZ | 29 Dec 2023 |